Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (18 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Product
9
20
25
30
Service
12
19
24
33
Total revenue
21
39
50
63
Product
4
8
11
13
Service
8
10
13
16
Total cost of revenue
12
19
24
30
Gross Profit
8
20
25
33
Research and development
2
2
7
11
Sales and Marketing
11
13
25
30
General and administrative
8
12
15
16
Total operating expenses
21
28
47
57
Loss from operations
-13
-7
-22
-24
Interest expense, net
-1
0
0
0
Foreign exchange losses
-1
0
0
0
Other income (expense)
0
0
0
0
Loss before income taxes
-15
-9
-22
-24
Income tax expense
0
0
0
0
Net loss
-15
-9
-22
-24
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
76
50
84
Restricted cash
n/a
0
0
0
Accounts receivable, net
n/a
5
7
7
Inventory
n/a
5
6
7
Prepaid expenses and other assets
n/a
2
3
4
Total current assets
n/a
89
66
101
Restricted cash, non-current
n/a
0
0
0
Property and equipment, net
n/a
3
5
6
In-process research and development
n/a
0
2
2
Goodwill
n/a
0
0
0
Other intangible assets, net
n/a
0
0
0
Other assets
n/a
0
0
0
Total assets
n/a
93
74
110
Liabilities and owners' equity
Accounts payable
n/a
2 2310000
2 2368000
4 3799000
Accrued liabilities
n/a
7 6936000
7 7070000
10 9949000
Deferred income
n/a
2 1540000
2 1993000
2 1654000
Current portion of loans payable
n/a
0 170000
0 137000
0 79000
Taxes payable
n/a
0 177000
0 0
0 0
Total current liabilities
n/a
11 11133000
12 11568000
15 15481000
Long-term portion of loans payable
n/a
1 563000
0 454000
0 386000
Contingent purchase price consideration
n/a
0 0
1 1218000
1 1293000
Other liabilities
n/a
0 296000
0 0
0 0
Total liabilities
n/a
12 11992000
13 13240000
17 17160000
Commitments and contingencies (Note 16)
n/a
0 0
0 0
0 0
Ordinary Shares
n/a
0 188000
0 192000
0 243000
Additional paid-in capital
n/a
184 183967000
187 186816000
244 244033000
Accumulated deficit
n/a
-100 -99655000
-122 -121829000
-146 -146307000
Accumulated other comprehensive loss
n/a
-4 -3748000
-5 -4570000
-5 -5277000
Total shareholders’ equity
n/a
81 80752000
61 60609000
93 92692000
Total liabilities and shareholders’ equity
n/a
93 92744000
74 73849000
110 109852000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net loss
-15
-9
-22
-24
Depreciation and amortization
1
1
2
2
Intangible assets impairment charges
0
0
0
0
Share-based compensation expense
0
0
3
3
Change in fair value of contingent purchase price consideration
0
0
0
0
Loss on change in fair value of warrants
0
0
0
0
Loss on change in fair value of derivative instrument
0
1
0
0
Loss (gain) on disposal of property and equipment
0
0
0
0
Noncash interest expense
1
0
0
0
Accounts receivable, net
-3
1
-2
0
Inventory
-1
-3
-1
-1
Prepaid expenses and other assets
0
-1
-1
-1
Accounts payable
0
0
0
1
Accrued liabilities
2
3
1
3
Deferred income
1
1
1
0
Net cash used in operating activities
-14
-6
-21
-17
Purchases of property and equipment
-1
-2
-3
-3
Purchases of intangible assets
0
0
0
0
Cash paid for acquisition, net of cash acquired
0
0
-2
0
Proceeds on sales of property and equipment
0
0
0
0
Decrease in restricted cash
0
0
0
0
Proceeds from revolving line of credit
2
0
0
0
Net cash used in investing activities
-2
-2
-5
-3
Proceeds from convertible note
4
5
0
0
Proceeds received in advance of share issuance
8
0
0
0
Proceeds from issuance of ordinary shares
0
64
0
54
Proceeds from exercise of share options
0
0
0
0
Proceeds from issuance of preferred ordinary shares
13
3
0
0
Proceeds from term loan
0
7
0
0
Payments on loan
0
-6
0
0
Payments on revolving line of credit
0
-2
0
0
Net cash provided by (used in) financing activities
26
71
0
54
Effect of exchange rate changes on cash and cash equivalents
0
1
0
0
Net increase (decrease) in cash and cash equivalents, excluding restricted cash
10
64
-26
34
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,